Search
AIM ImmunoTech Inc
AIMAdd to Watchlist
0.257USD
+0.022+9.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.12MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of AIM ImmunoTech Inc is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 22.00, with a high of 22.00 and a low of 22.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
5.250
Target Price
+2087.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
AIM ImmunoTech Inc
AIM
2
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is AIM ImmunoTech Inc's price target?
Analysts forecast that AIM ImmunoTech Inc's price target is USD 22.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 22.00.
How have AIM ImmunoTech IncAIM's recent earnings per share performed?
The market expectation was USD -0.69, while AIM ImmunoTech IncAIM's earnings per share (EPS) for the previous quarter was USD -1.44. EPS for the next quarter is expected at USD -0.17.
What is the analyst rating for AIM ImmunoTech Inc?
Based on the ratings of AIM ImmunoTech Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.